Unique visual stimulation may be new treatment for Alzheimer’s
Using LED lights flickering at a specific frequency, MIT researchers have shown that they can substantially reduce the beta amyloid plaques seen in Alzheimer’s disease, in the visual cortex of mice. This treatment appears to work by inducing brain waves known as gamma oscillations, which the researchers discovered help the…
Read MoreMRIs for fetal health
Algorithm could help analyze fetal scans to determine whether interventions are warranted. Researchers from MIT, Boston Children’s Hospital, and Massachusetts General Hospital have joined forces in an ambitious new project to use magnetic resonance imaging (MRI) to evaluate the health of fetuses. Typically, fetal development is monitored with ultrasound imaging,…
Read MoreMIT shares $75 million grant to fight heart disease
One Brave Idea Research Award will support the search for new biomarkers and treatments. MIT is one of the institutions that will share the One Brave Idea Research Award to pursue new biomarkers for atherosclerosis — the hardening of the arteries that kills about 500,000 people in the United States…
Read MoreNanosensors could help determine tumors’ ability to remodel tissue
Measuring enzyme levels could help doctors select appropriate treatments. MIT researchers have designed nanosensors that can profile tumors and may yield insight into how they will respond to certain therapies. The system is based on levels of enzymes called proteases, which cancer cells use to remodel their surroundings. Once adapted…
Read MoreDavid Cohen steps down as HST Director
Dr. David Cohen, co-Director of the Harvard-MIT Health Sciences and Technology (HST) program and the Robert H. Ebert Professor of Medicine at Harvard Medical School, is stepping down after a nine-year tenure and will become Chief of Gastroenterology and Hepatology in the Department of Medicine at Weill Cornell Medical College…
Read More